NCT03750526

Brief Summary

This study is to investigate the combined effects of repetitive Transcranial Magnetic Stimulation (rTMS) and Augmented Reality (AR) intervention on cortical excitability, balance, gait, activity in individuals with stroke. Forty participants will be recruited in this study. They will be allocated to four group: rTMS and AR group (10), sham rTMS and AR group (10), AR group (10), and conventional physiotherapy group (10).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Jul 2018

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 31, 2018

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 20, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 23, 2018

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

January 31, 2023

Status Verified

January 1, 2023

Enrollment Period

5.3 years

First QC Date

November 20, 2018

Last Update Submit

January 27, 2023

Conditions

Keywords

Repetitive transcranial magnetic stimulation (rTMS)Augmented reality (AR)stroke

Outcome Measures

Primary Outcomes (1)

  • Change of Time Up Go test (TUG)

    The TUG test will ask participants to stand up, walk for 3 m, turn, walk back and sit down as fast as they can during the test, and the time requires for each patient to complete the test is recorded.

    Measurement before and after intervention ( week 0 and at the end of week 4) in four groups

Secondary Outcomes (6)

  • Change of Berg Balance Scale (BBS)

    Measurement before and after intervention ( week 0 and at the end of week 4) in four groups

  • Change of Motor evoked potential (MEP)

    Measurement before and after intervention ( week 0 and at the end of week 4) in four groups

  • Change of Fugl-Meyer Assessment (FMA)-Lower extremity

    Measurement before and after intervention ( week 0 and at the end of week 4) in four groups

  • Change of Multi-directional Reach Test (MDRT)

    Measurement before and after intervention ( week 0 and at the end of week 4) in four groups

  • Change of The Postural Assessment Scale for Stroke Patients (PASS)

    Measurement before and after intervention ( week 0 and at the end of week 4) in four groups

  • +1 more secondary outcomes

Study Arms (4)

rTMS and AR group

EXPERIMENTAL

Ten participants in group A will undergo repetitive transcranial magnetic stimulation (real, 1 Hz, 15 minutes), follow by a session of augmented reality exercise (45 minutes), 3 days per week for 4 weeks.

Behavioral: rTMS and AR

Sham rTMS and AR group

ACTIVE COMPARATOR

Ten participants in group B will receive repetitive transcranial magnetic stimulation (sham,1 Hz, 15 minutes), follow by a session of augmented reality exercise (45 minutes), 3 days per week for 4 weeks.

Behavioral: Sham rTMS and AR

AR group

ACTIVE COMPARATOR

Ten participants in group C will undergo augmented reality exercise 60 minutes a day and 3 days per week for four weeks.

Behavioral: AR

Conventional physiotherapy group

ACTIVE COMPARATOR

Ten participants allocated to the group D will receive conventional physiotherapy 60 minutes a day and 3 days per week for four weeks.

Behavioral: Conventional physiotherapy

Interventions

rTMS and ARBEHAVIORAL

rTMS performs 1Hz,15 minutes real rTMS. AR intervention contains weight-shift exercise, strengthening of lower limb and balance training for 45 minutes.

rTMS and AR group

Sham rTMS applies 1Hz, 15 minutes sham rTMS. AR intervention includes weight-shift exercise, strengthening of lower limb and balance training for 45 minutes.

Sham rTMS and AR group
ARBEHAVIORAL

AR intervention contains weight-shift exercise, strengthening of lower limb and balance training for 60 minutes.

AR group

Conventional physiotherapy includes rolling, sitting, balance exercise, standing, overground walking, facilitation of the paretic limbs, and so on for 60 minutes.

Conventional physiotherapy group

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cognitive ability is sufficient to understand the nature of study (Mini-Mental State Examination score was above 23).
  • Participants suffer from unilateral hemiplegia caused by a first-ever stroke.
  • Participants are stable in medical and psychological condition.

You may not qualify if:

  • Participants have other neurologic problems that can affect balance and walking ability.
  • Participants take of drugs or have other medical condition that can affect balance and function.
  • Participants have contraindications for rTMS intervention such as pacemaker, cochlear implants, metal in the brain or skull, open wound of brain, or history of epilepsy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Medical university Hospital

Taipei, Taiwan

RECRUITING

MeSH Terms

Conditions

Stroke

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Study Officials

  • Chien-Hung Lai, MD PhD

    Taipei Medical University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Chien-Hung Lai, MD PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 20, 2018

First Posted

November 23, 2018

Study Start

July 31, 2018

Primary Completion

October 30, 2023

Study Completion

December 30, 2023

Last Updated

January 31, 2023

Record last verified: 2023-01

Locations